Lenox D. Martin

838 total citations
15 papers, 692 citations indexed

About

Lenox D. Martin is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Lenox D. Martin has authored 15 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Lenox D. Martin's work include Mast cells and histamine (3 papers), Pain Mechanisms and Treatments (3 papers) and Receptor Mechanisms and Signaling (3 papers). Lenox D. Martin is often cited by papers focused on Mast cells and histamine (3 papers), Pain Mechanisms and Treatments (3 papers) and Receptor Mechanisms and Signaling (3 papers). Lenox D. Martin collaborates with scholars based in United States, United Kingdom and China. Lenox D. Martin's co-authors include Don E. Griswold, James J. Foley, Henry M. Sarau, John R. White, Katherine L. Widdowson, Robert Hertzberg, Judithann M. Lee, Anthony J. Jurewicz, Peter R. Young and Margery A. Chaikin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lenox D. Martin

15 papers receiving 659 citations

Peers

Lenox D. Martin

IMMUN

ONCOL

PHYSI

MB

CMN

Mark Christie United Kingdom

Yuntao Wan United States

Jill Reckless United Kingdom

Monika Niehof Germany

Mária Magócsi Hungary

Roberto Bomprezzi United States

A. Genovese Italy

Ian Fisher United States

Eileen McCall United Kingdom

Tony J. Savage United Kingdom

Mark Christie United Kingdom

Lenox D. Martin

175 ×0.7

IMMUN

150 ×0.6

ONCOL

103 ×0.6

PHYSI

156 ×0.9

MB

45 ×0.4

CMN

Citations per year, relative to Lenox D. Martin Lenox D. Martin (= 1×) peers Mark Christie

Countries citing papers authored by Lenox D. Martin

Since Specialization

Citations

This map shows the geographic impact of Lenox D. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenox D. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenox D. Martin more than expected).

Fields of papers citing papers by Lenox D. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenox D. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenox D. Martin. The network helps show where Lenox D. Martin may publish in the future.

Co-authorship network of co-authors of Lenox D. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Lenox D. Martin. A scholar is included among the top collaborators of Lenox D. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenox D. Martin. Lenox D. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Widdowson, Katherine L., John D. Elliott, Daniel F. Veber, et al.. (2004). Evaluation of Potent and Selective Small-Molecule Antagonists for the CXCR2 Chemokine Receptor. Journal of Medicinal Chemistry. 47(6). 1319–1321. 59 indexed citations

2.

Hay, Douglas W.P., Giuseppe Giardina, Don E. Griswold, et al.. (2002). Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs. Journal of Pharmacology and Experimental Therapeutics. 300(1). 314–323. 75 indexed citations

3.

Griswold, Don E., Stephen A. Douglas, Lenox D. Martin, et al.. (2000). Targeted Disruption of the Endothelin-B-Receptor Gene Attenuates Inflammatory Nociception and Cutaneous Inflammation in Mice. Journal of Cardiovascular Pharmacology. 36. S78–S81. 3 indexed citations

4.

Buckett, Linda K., Peter Ballard, Robert G. Davidson, et al.. (2000). Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells. Atherosclerosis. 151(1). 41–41. 53 indexed citations

5.

Griswold, Don E., Stephen A. Douglas, Lenox D. Martin, et al.. (2000). Targeted Disruption of the Endothelin-B-Receptor Gene Attenuates Inflammatory Nociception and Cutaneous Inflammation in Mice. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S78–S81. 11 indexed citations

6.

Griswold, Don E., Lenox D. Martin, Laura Davis, et al.. (1999). Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation. Molecular Pharmacology. 56(4). 807–812. 68 indexed citations

7.

Sarau, Henry M., James J. Foley, Dulcie B. Schmidt, et al.. (1999). In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4receptor antagonist with anti-inflammatory activity. Prostaglandins Leukotrienes and Essential Fatty Acids. 61(1). 55–64. 6 indexed citations

8.

White, John R., Judithann M. Lee, Peter R. Young, et al.. (1998). Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration. Journal of Biological Chemistry. 273(17). 10095–10098. 341 indexed citations

9.

Medhurst, Andrew D., Douglas W.P. Hay, Andrew A. Parsons, Lenox D. Martin, & Don E. Griswold. (1997). In vitro and in vivo characterization of NK₃ receptors in the rabbit eye by use of selective non‐peptide NK₃ receptor antagonists. British Journal of Pharmacology. 122(3). 469–476. 31 indexed citations

10.

DAINES, R. A., Pamela A. Chambers, James J. Foley, et al.. (1996). (E)-3-[6-[[(2,6-Dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2- propenoic Acid: A High-Affinity Leukotriene B₄ Receptor Antagonist with Oral Antiinflammatory Activity. Journal of Medicinal Chemistry. 39(19). 3837–3841. 13 indexed citations

11.

Griswold, Don E., Marie Chabot‐Fletcher, Edward F. Webb, Lenox D. Martin, & Leonard M. Hillegass. (1995). Antiinflammatory activity of topical auranofin in arachidonic acid‐ and phorbol ester‐induced inflammation in mice. Drug Development Research. 34(4). 369–375. 1 indexed citations

12.

DAINES, R. A., Pamela A. Chambers, Drake S. Eggleston, et al.. (1994). (E)-3-[[[[6-(2-Carboxyethenyl)-5-[[8-(4-methoxyphenyl)octyl]oxy]-2-pyridinyl]methyl]thio]methyl]benzoic Acid and Related Compounds: High Affinity Leukotriene B4 Receptor Antagonists. Journal of Medicinal Chemistry. 37(20). 3327–3336. 13 indexed citations

13.

DAINES, R. A., Pamela A. Chambers, Israil Pendrak, et al.. (1993). Additions and Corrections - (E)-3-[[[[[6-(2-Carboxyethenyl)-5-[[8-(4-methoxyphenyl)octy-1]oxy]-2-pyridinyl]methyl]thio]methyl]benzoic Acid: A Novel High-Affinity Leukotriene B₄ Receptor Antagonist.. Journal of Medicinal Chemistry. 36(25). 4130–4130. 1 indexed citations

14.

Griswold, Don E., et al.. (1991). Technique for quantification of LTB4-lnduced changes in peripheral granulocyte counts in vivo in the rabbit. Journal of Pharmacological Methods. 25(4). 319–328. 3 indexed citations

15.

Griswold, D.E., et al.. (1991). Analgetic Activity of SK&F 105809, a Dual Inhibitor of Arachidonic Acid Metabolism. Birkhäuser Basel eBooks. 32. 113–117. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact